Professor Peter Barrett-Lee

Professor Peter Jeffery Barrett-Lee MBBS BSc MD (Lond) FRCR FRCP (Edin) FRCP (Lond)     I have a leading role for breast cancer academic scientific research at Velindre University NHS Trust, and Cardiff University. The Velindre Cancer Centre based in North Cardiff provides specialist cancer services to over 1.5 million people living in South East Wales.   My own NHS practice based at the Velindre Cancer Centre includes clinical trials research and I am a past member of the UK NCRI Breast Group (elected 2004), where I also helped develop & present national guidelines for the monitoring & management of cardiac effects from the use of adjuvant trastuzumab (Herceptin) therapy. I was elected Chair of the UK Breast Cancer Intergroup (2009-12) charged by the NCRI with developing the next generation of clinical trials in the UK. I have been Co-Principal Investigator on three large UK trials with nearly 10,000 patients randomised (TACT, TACT2, ZICE).  I am member & Past Secretary of the British Breast Group, a national multidisciplinary society running scientific meetings twice annually & whose membership includes many of the scientific & clinical leaders in the field. In 2012, I became Professor of Breast Cancer Studies (2 sessions) at Cardiff University.   I stepped down as Medical Director of Velindre NHS Trust having had responsibilities for both our Divisions - Velindre Cancer Centre and The Welsh Blood Service including being the Responsible Officer since 2010. I have treated the first patients ever in the UK with Proton Beam Therapy for Breast Cancer at the sadly defunct Rutherford Cancer Centre, Newport. I have also in the past been intimately involved with Innovation at Velindre, and am part of the team leading on our IBM/Watson Chatbot called Rita. I am now the clinical lead for private patients at Velindre and also clinical lead for patient concerns and complaints.

Breast cancer Chemotherapy X-ray Treatments Immunotherapy Hormone therapy